195 related articles for article (PubMed ID: 30704797)
1. Ten-year experience with multimodal treatment for acute phase Peyronie's disease: A real life clinical report.
Gallo L; Sarnacchiaro P
Actas Urol Esp (Engl Ed); 2019 May; 43(4):182-189. PubMed ID: 30704797
[TBL] [Abstract][Full Text] [Related]
2. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease.
Abern MR; Larsen S; Levine LA
J Sex Med; 2012 Jan; 9(1):288-95. PubMed ID: 22024053
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial.
Ziegelmann M; Savage J; Toussi A; Alom M; Yang D; Kohler T; Trost L
J Urol; 2019 Sep; 202(3):599-610. PubMed ID: 30916626
[TBL] [Abstract][Full Text] [Related]
4. Current approach to the man with acute phase Peyronie's disease--case presentation and discussion.
Levine LA
J Sex Med; 2011 Jun; 8(6):1556-8; quiz 1559. PubMed ID: 21631731
[No Abstract] [Full Text] [Related]
5. Intralesional verapamil prevents the progression of Peyronie's disease.
Bennett NE; Guhring P; Mulhall JP
Urology; 2007 Jun; 69(6):1181-4. PubMed ID: 17572211
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
[TBL] [Abstract][Full Text] [Related]
7. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study.
Moncada I; Krishnappa P; Romero J; Torremade J; Fraile A; Martinez-Salamanca JI; Porst H; Levine L
BJU Int; 2019 Apr; 123(4):694-702. PubMed ID: 30365247
[TBL] [Abstract][Full Text] [Related]
8. Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial.
Greenfield JM; Shah SJ; Levine LA
J Urol; 2007 Mar; 177(3):972-5. PubMed ID: 17296390
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
Alom M; Sharma KL; Toussi A; Kohler T; Trost L
J Sex Med; 2019 Jun; 16(6):891-900. PubMed ID: 30956106
[TBL] [Abstract][Full Text] [Related]
10. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
Rehman J; Benet A; Melman A
Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of verapamil efficacy in Peyronie's disease comparing with pentoxifylline.
Alizadeh M; Karimi F; Fallah MR
Glob J Health Sci; 2014 Sep; 6(7 Spec No):23-30. PubMed ID: 25363175
[TBL] [Abstract][Full Text] [Related]
12. A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.
Toscano L; Rezende MV; Mello LF; Paulillo D; Glina S
Int Braz J Urol; 2016; 42(5):1005-1009. PubMed ID: 24893912
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease.
Yafi FA; Pinsky MR; Stewart C; Sangkum P; Ates E; Trost LW; Sikka SC; Hellstrom WJ
J Urol; 2015 Sep; 194(3):754-8. PubMed ID: 25804087
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
[TBL] [Abstract][Full Text] [Related]
15. Experience with intraplaque injection of verapamil for Peyronie's disease.
Levine LA; Goldman KE; Greenfield JM
J Urol; 2002 Aug; 168(2):621-5; discussion 625-6. PubMed ID: 12131321
[TBL] [Abstract][Full Text] [Related]
16. Effect of Penile Traction and Vacuum Erectile Device for Peyronie's Disease in an Animal Model.
Lin H; Liu C; Wang R
J Sex Med; 2017 Oct; 14(10):1270-1276. PubMed ID: 28923308
[TBL] [Abstract][Full Text] [Related]
17. Intralesional injection of the calcium channel blocker Verapamil in Peyronie's disease: A critical review.
Asali M; Asali M
Arch Ital Urol Androl; 2020 Oct; 92(3):. PubMed ID: 33016057
[TBL] [Abstract][Full Text] [Related]
18. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature.
Russo GI; Milenkovic U; Hellstrom W; Levine LA; Ralph D; Albersen M
Eur Urol; 2018 Dec; 74(6):767-781. PubMed ID: 30237020
[TBL] [Abstract][Full Text] [Related]
19. Defining predictors of response to intralesional verapamil injection therapy for Peyronie's disease.
Moskovic DJ; Alex B; Choi JM; Nelson CJ; Mulhall JP
BJU Int; 2011 Nov; 108(9):1485-9. PubMed ID: 21733073
[TBL] [Abstract][Full Text] [Related]
20. Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease.
Cavallini G; Modenini F; Vitali G
Urology; 2007 May; 69(5):950-4. PubMed ID: 17482941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
